This study not only provides critical mechanistic insight into the potential protective effect of Set7_1a against HIF-1α degradation by inhibiting SET7/9 function and antagonizing HIF-1α methylation in hypoxia and hyperglycemia but also validates the feasibility of targeting SET7/9 methyltransferase activity for treating diabetic wounds. This evidence concerns the gene SETD7 and Hyperglycemia.